ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Calculator: UCLA Integrated Staging System (UISS) prognostic model for adults with renal cell carcinoma treated with nephrectomy


Calculator: UCLA Integrated Staging System (UISS) prognostic model for adults with renal cell carcinoma treated with nephrectomy

 
Input
 
Disease type Localized

Metastatic
Fuhrman nuclear grade  
ECOG performance status 0: Fully active; no performance restrictions

1: Strenuous physical activity restricted; fully ambulatory and able to carry out light work

2: Capable of all self-care but unable to carry out any work activities; up and about >50% of waking hours

3: Capable of only limited self-care; confined to bed or chair >50% of waking hours

4: Completely disabled; cannot carry out any self-care; totally confined to bed or chair
T-Stage Not applicable to metastatic disease

T1

T2

T3/T4
NM-Stage Not applicable for localized disease

N1M0

N2M0/M1

 

 
Important: Inputs must be complete to perform calculation.

 

 

UISS interpretation for local disease

 
T-stage Fuhrman ECOG PS Risk 5-year disease-free survival
T1 1 to 2 0 Low 91.1%
T1 1 to 2 1 to 4 Intermed 80.4%
T1 3 to 4 0 to 4 Intermed 80.4%
T2 1 to 4 0 to 4 Intermed 80.4%
T3 1 0 to 4 Intermed 80.4%
T3 2 to 4 0 Intermed 80.4%
T3 2 to 4 1 to 4 High 54.7%

 

 

UISS interpretation for metastatic disease

 
NM-stage Fuhrman ECOG PS Risk 5-year disease-free survival
N1M0 1 to 4 0 to 4 Low 32%
N2M0/M1 1 0 Low 32%
N2M0/M1 1 1 to 4 Intermed 19.5%
N2M0/M1 2 0 Low 32%
N2M0/M1 2 1 to 4 Intermed 19.5%
N2M0/M1 3 0 to 4 Intermed 19.5%
N2M0/M1 4 0 Intermed 19.5%
N2M0/M1 4 1 to 4 High <1%

 
 

 

 
Notes
  • This model[1,2] uses the 1997 American Joint Committee on Cancer (AJCC) Tumor (T), Node (N), and Metastatic (M) staging system.[3] Localized disease is defined as any T and N0 and M0. Metastatic disease is defined as any T and N≥1 and M≥0. For more information regarding contemporary staging systems, please refer to UpToDate discussion of staging of renal cell carcinoma.
  • This prognostic model has been validated through observational studies; however, it has not been validated in large groups of patients treated with immune checkpoint inhibitors and other targeted agents.
  • ECOG: Eastern Cooperative Oncology Group; PS: performance status; Intermed: Intermediate.

 
Only digits 0 to 9 and a single decimal point (".") are acceptable as numeric inputs. Attempted input of other characters into a numeric field may lead to an incorrect result.

Information on this page may not appear correctly if printed.

Legal Notices and Disclaimer

All information contained in and produced by the EBMcalc system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. Click here for full notice and disclaimer.

EBMcalc is Copyright © 1998-2024 Foundation Internet Services, LLC

Topic 140668 Version 2.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟